Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
Miura R, Ono A, Nakahara H, Shirane Y, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Murakami E, Kawaoka T, Miki D, Tsuge M, Kishi T, Ohishi W, Sakamoto N, Arihiro K, Hayes CN, Oka S. Miura R, et al. Among authors: murakami e. J Gastroenterol. 2024 Dec 9. doi: 10.1007/s00535-024-02185-w. Online ahead of print. J Gastroenterol. 2024. PMID: 39652104
Mucosal cytokine expression associated with deep endoscopic mucosal healing in ulcerative colitis.
Uchiyama K, Takagi T, Mizushima K, Hirai Y, Murakami E, Asaeda K, Kajiwara-Kubota M, Kashiwagi S, Minagawa Y, Hotta Y, Tanaka M, Inoue K, Katada K, Kamada K, Ishikawa T, Konishi H, Kishimoto M, Naito Y, Itoh Y. Uchiyama K, et al. Among authors: murakami e. J Crohns Colitis. 2024 Oct 16:jjae158. doi: 10.1093/ecco-jcc/jjae158. Online ahead of print. J Crohns Colitis. 2024. PMID: 39412247
Real-world efficacy and safety of durvalumab-tremelimumab as second-line systemic therapy after atezolizumab-bevacizumab in unresectable hepatocellular carcinoma.
Miura R, Ono A, Yano S, Amioka K, Naruto K, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Nakahara T, Murakami E, Kawaoka T, Miki D, Tsuge M, Hayes CN, Oka S. Miura R, et al. Among authors: murakami e. Medicine (Baltimore). 2024 Aug 23;103(34):e39289. doi: 10.1097/MD.0000000000039289. Medicine (Baltimore). 2024. PMID: 39288227 Free PMC article.
The association between initiation weekday of radiotherapy and local control in stage 1 glottic carcinoma: a retrospective analysis.
Endo M, Takahashi S, Fukuda Y, Okada K, Ogawa K, Nakamura M, Kawahara M, Akahane K, Murakami E, Shibayama C, Onaga R, Nagatomo T, Kanazawa T, Nishino H, Mori H, Shirai K. Endo M, et al. Among authors: murakami e. J Radiat Res. 2024 Dec 3;65(6):798-804. doi: 10.1093/jrr/rrae074. J Radiat Res. 2024. PMID: 39287117 Free PMC article.
503 results